Nature Medicine, Published online: 20 May 2026; doi:10.1038/s41591-026-04384-9
The authors examine the vaccine landscape through two key areas of research and development—expanding target populations, and emerging vaccine technologies—and discuss cross-cutting issues, including the societal value of vaccines, funding and access, and regional manufacturing.
